KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 120 filers reported holding KRYSTAL BIOTECH INC in Q2 2021. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,986,328 | +23.3% | 698,158 | +24.8% | 0.24% | +21.0% |
| Q2 2023 | $65,657,241 | +63.2% | 559,261 | +11.3% | 0.20% | +56.0% |
| Q1 2023 | $40,222,144 | -8.7% | 502,400 | -9.7% | 0.12% | -16.7% |
| Q4 2022 | $44,066,283 | -49.8% | 556,252 | -55.8% | 0.15% | -57.1% |
| Q3 2022 | $87,718,000 | -15.1% | 1,258,505 | -20.1% | 0.35% | -19.7% |
| Q2 2022 | $103,367,000 | -9.7% | 1,574,275 | -8.5% | 0.44% | -4.0% |
| Q1 2022 | $114,467,000 | -11.8% | 1,720,267 | -7.3% | 0.45% | -12.4% |
| Q4 2021 | $129,838,000 | +365.1% | 1,856,156 | +247.1% | 0.52% | +321.1% |
| Q3 2021 | $27,917,000 | +20.4% | 534,700 | +56.8% | 0.12% | +18.3% |
| Q2 2021 | $23,181,000 | +78.0% | 340,900 | +101.7% | 0.10% | +70.5% |
| Q1 2021 | $13,020,000 | -56.6% | 169,000 | -66.2% | 0.06% | -58.2% |
| Q4 2020 | $30,000,000 | +5.0% | 500,000 | -24.7% | 0.15% | 0.0% |
| Q3 2020 | $28,580,000 | +28.0% | 663,889 | +23.1% | 0.15% | 0.0% |
| Q2 2020 | $22,335,000 | +445.4% | 539,242 | +430.2% | 0.15% | +595.2% |
| Q2 2019 | $4,095,000 | +48.0% | 101,700 | +21.0% | 0.02% | +61.5% |
| Q1 2019 | $2,766,000 | – | 84,084 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 2,003,367 | $232,390,572 | 11.06% |
| Frazier Life Sciences Management, L.P. | 988,460 | $114,661,360 | 7.62% |
| S Squared Technology, LLC | 108,215 | $12,552,940 | 6.77% |
| Avoro Capital Advisors LLC | 2,565,555 | $297,604,380 | 4.64% |
| APIS CAPITAL ADVISORS, LLC | 24,000 | $2,784,000 | 3.61% |
| Nicholas Investment Partners, LP | 355,611 | $41,250,876 | 3.08% |
| Ghost Tree Capital, LLC | 80,000 | $9,280,000 | 3.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 71,531 | $8,297,596 | 2.52% |
| Affinity Asset Advisors, LLC | 57,500 | $6,670,000 | 1.88% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 46,092 | $5,344,828 | 1.80% |